XM
CTMX icon

XTX Markets’s CytomX Therapeutics CTMX Stock Holding History

XTX Markets’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$93K Buy
+14,169
New +$101K 0.19% 169

Other funds holding CTMX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Markets's CTMX Position: Q4 2020 in Review

XTX Markets opened a new position in CytomX Therapeutics (CTMX) in Q4 2020: 14,169 shares worth $93K. The stake represents 0.19% of the portfolio and ranks #169 among its holdings.

126 funds tracked by Wall St. Rank hold CTMX as of Q4 2020.

  • XTX Markets held 14,169 shares of CytomX Therapeutics worth $93K as of Q4 2020.
  • CytomX Therapeutics was a new XTX Markets position in Q4 2020.
  • CytomX Therapeutics made up 0.19% of XTX Markets's portfolio in Q4 2020, its #169 holding.
  • 126 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.